HISTOLOGY-BASED AI FOR ONCOLOGY
Your biopsy holds more than it shows.
AI reveals what the eye alone can’t see.
PRODUCTS
BIOMARKER SCORING
DiaKwant®
AI biomarker quantification
RECURRENCE RISK*DiaSurv® *
Personalised recurrence-risk assessment
TREATMENT RESPONSE*DiaThera® *
Treatment-response prediction
Available for clinical use.
DiaKwant quantifies and scores
AVAILABLE
Directly in your image management system.
EVIDENCE
See how our AI assays were evaluated.
See how the study populations and results relate to the cases you encounter.
View all publications ↗︎Artificial Intelligence applied to surgical pathology in the management of cutaneous melanoma
01 OCT 2026 · PUBLICATION↗︎Validation of DiaSurv an AI-Based Algorithm for Stage II Colon Risk Stratification
2026 · PUBLICATION↗︎Impact of artificial intelligence assistance on combined PD-L1 scoring on whole immunohistochemical slide image of tumours
05 SEPT 2026 · PUBLICATION↗︎BEHIND THE EVIDENCE
In partnership with clinical and scientific teams.
LATEST
What’s happening at DiaDeep.
Company milestones, media coverage and upcoming events, all in one place.
View all resources ↗︎WHERE TO START
I am a pathologist
Send us a case you hesitated on. Share an anonymized slide close to the cutoff. We send back the score with the cells and counts behind it. Free, straight from your browser.
↗︎I am a clinician
Talk with our R&D team. Ask how our results can inform adjuvant and treatment decisions, and which clinical studies are open.
↗︎I have a research project
Connect your clinical question with a prognosis or treatment-response project.
↗︎ONE SLIDE. THREE PATHS FORWARD.
The next clinical insight may already be in the slide.
Whether you need to quantify a biomarker, stratify risk or explore treatment response, bring us your clinical question. Together, we’ll define the right path from tissue to insight.